Baxter Healthcare Corporation
Based in IL
🤖
AI Overview
With $1.6M in lobbying spend across 31 quarterly filings, Baxter Healthcare Corporation is a significant lobbying presence.
$1.6M
Total Lobbying Spend
31
Quarterly Filings
1
Lobbying Firms Used
9
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $180K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $150K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $260K |
| 2025 | $220K |
Lobbying Firms
THE NICKLES GROUP, LLC
What They Lobby For
- Disaster recovery infrastructure issues related to the hurricanes.
- Monitor implementation of H.R. 1, The Tax Cut and Jobs Act, and issues related to corporate tax reform and the taxation of U.S. multinational corporations. Issues related to Puerto Rico. Issues related to the medical device tax.
- Monitored issues related to pharmaceutical prices. H.R. 1625, Consolidated Appropriations Act of 2018. H.R. 1892, Bipartisan Budget Act of 2018. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment.
- H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to telehealth and remote monitoring of patients.
- S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 3178, Medicare Part B Improvement Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding care for chronic diseases, including telehealth issues such as home as originating site and remote monitoring of home dialysis patients. Issues related to ESRD PPS. H.R. 1625, Consolidated Appropriations Act of 2018.
- Issues related to ESRD PPS and innovative device reimbursement policies.
- Monitor implementation of The Tax Cut and Jobs Act as it relates to corporate tax reform and the taxation of U.S. multinational corporations. Issues related to Puerto Rico. Issues related to the medical device tax.
- Monitored issues related to pharmaceutical prices. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment. H.R. 6, SUPPORT for Patients and Communities Act, S. 2680, Opioid Crisis Response Act of 2018. Issues related to Pandemic and All-Hazards Preparedness and S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI); monitored issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory.
- Monitor implementation of The Tax Cut and Jobs Act as it relates to corporate tax reform and the taxation of U.S. multinational corporations. Issues related to the medical device tax.
- Monitored issues related to pharmaceutical prices. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment. H.R. 6, SUPPORT for Patients and Communities Act, S. 2680, Opioid Crisis Response Act of 2018. Issues related to Pandemic and All-Hazards Preparedness and S. 2852 / H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPA); monitored issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.